Scalable, high-quality pDNA platform to accelerate AAV manufacturing
Event Information
Event description
Boston Institute of Biotechnology (BIB) is a fast-growing CDMO providing advanced CMC services for biologics and gene therapy.
About this Event
Gene therapy is a fast-growing industry. Demand for its products such as pDNA, AAV, retrovirus, lentivirus, etc. has significantly increased during the last 10 years while its production challenges remain unresolved. It is a complex process with a number of unoptimized and low yielding steps.
A typical process development (PD) cycle from preclinical to late-phase manufacturing (Mfg) takes 3 to 5 years. It is desired to rapidly advance the manufacturing for early clinical candidates using well established and high yielding processes
What you can learn:
- BIB’s platform approach for accelerated process development and scale-up production for pDNA and AAV
- Our efficient DoE application for process optimization and characterization
- Case studies for BIB pDNA and AAV production platforms
Need more information?
Visit us at Bostonbib.com
Connect with our expert via Contact us
Call us at 1-833-818-CDMO(2366)
